Your browser doesn't support javascript.
loading
Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.
Hamadani, Mehdi; Collins, Graham P; Caimi, Paolo F; Samaniego, Felipe; Spira, Alexander; Davies, Andrew; Radford, John; Menne, Tobias; Karnad, Anand; Zain, Jasmine M; Fields, Paul; Havenith, Karin; Cruz, Hans G; He, Shui; Boni, Joseph; Feingold, Jay; Wuerthner, Jens; Horwitz, Steven.
Afiliação
  • Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Collins GP; National Institute for Health Research Oxford Biomedical Research Centre, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, UK.
  • Caimi PF; Case Western Reserve University-University Hospitals Cleveland Medical Center, OH, USA.
  • Samaniego F; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Spira A; Virginia Cancer Specialists Research Institute, Fairfax, VA, USA; Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Davies A; Cancer Research UK and National Institute for Health Research Experimental Cancer Medicines Centre, University of Southampton, Southampton, UK.
  • Radford J; National Institute for Health Research Manchester Clinical Research Facility, Manchester Academic Health Science Centre, University of Manchester and the Christie NHS Foundation Trust, Manchester, UK.
  • Menne T; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Karnad A; Cancer Therapy and Research Center, The University of Texas Health Science Center, San Antonio, TX, USA.
  • Zain JM; Comprehensive Cancer Center, City of Hope Duarte, Duarte, CA, USA.
  • Fields P; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Havenith K; ADC Therapeutics, London, UK.
  • Cruz HG; ADC Therapeutics, Epalinges, Switzerland.
  • He S; ADC Therapeutics, Murray Hill, NJ, USA.
  • Boni J; ADC Therapeutics, Murray Hill, NJ, USA.
  • Feingold J; ADC Therapeutics, Murray Hill, NJ, USA.
  • Wuerthner J; ADC Therapeutics, Epalinges, Switzerland.
  • Horwitz S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: horwitzs@mskcc.org.
Lancet Haematol ; 8(6): e433-e445, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34048682
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Linfoma Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Linfoma Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos